GOAT links dietary lipids with the endocrine control of energy balance
It targets glucagon-like peptide-1, gastric inhibitory polypeptide, and glucagon receptors, creating a triple-action approach that regulates hunger, increases insulin production, and promotes fat metabolism
However, those clinical outcomes relied strictly on rigorous medical supervision, individualized dose titration, and continuous side-effect management not merely a shipped prescription pen
Prevention: After drawing your dose, hold the syringe needle-up
All studies used balanced populations (inverse probability of treatment weighting or propensity score matching) and accounted for informative censoring (inverse probability of censoring weighting)
[22] compared glucose metabolism parameters and post-prandial GLP-1 levels before and after MBS between patients with active or inactive Crohns Disease and healthy controls